5176 - 5200 of 8112 Results
Title
Year
- Phosphorylation of Ser111 in Rab8a Modulates Rabin8-Dependent Activation by Perturbation of Side Chain Interaction Networks2019OPENTitle: Phosphorylation of Ser111 in Rab8a Modulates Rabin8-Dependent Activation by Perturbation of Side Chain Interaction NetworksJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 33Start Page: 3546End Page: 3554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.biochem.9b00516Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2019/06/13/670729.full.pdfCitation Count: 9
-
RESTRICTEDTitle: Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 9Issue #: 3Start Page: 603End Page: 614Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191627Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191627?id=journal-of-parkinsons-disease%2Fjpd191627Citation Count: 82
- The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease2019OPENTitle: The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 9Issue #: 3Start Page: 553End Page: 563Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191648Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191648?id=journal-of-parkinsons-disease%2Fjpd191648Citation Count: 35
-
RESTRICTEDTitle: CONTRIBUTORSJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 25Issue #: 4Start Page: 888End Page: 892Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000578728.22103.71Citation Count: 0
- Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls2019OPENTitle: Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controlsJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1392End Page: 1398Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27807Best OA location URL: https://europepmc.org/articles/pmc6754269?pdf=renderCitation Count: 26
- Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism2019RESTRICTEDTitle: Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonismJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 158Issue #:Start Page: 107725End Page: 107725Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.107725Citation Count: 38
- Depressive symptoms precede cognitive impairment in de novo Parkinson’s disease patients: Analysis of the PPMI cohort.2019OPENTitle: Depressive symptoms precede cognitive impairment in de novo Parkinson’s disease patients: Analysis of the PPMI cohort.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 8Start Page: 1111End Page: 1120Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1037/neu0000583Best OA location URL: https://doi.org/10.1037/neu0000583Citation Count: 28
- Orthostatic hypotension as a risk factor for longitudinal deterioration of cognitive function in the elderly2019OPENTitle: Orthostatic hypotension as a risk factor for longitudinal deterioration of cognitive function in the elderlyJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 1Start Page: 160End Page: 167Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14050Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14050Citation Count: 20
-
OPENTitle: Parkinson’s progression prediction using machine learning and serum cytokinesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0086-4Best OA location URL: https://www.nature.com/articles/s41531-019-0086-4.pdfCitation Count: 94
- Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis2019OPENTitle: Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysisJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 22Issue #: 8Start Page: 1248End Page: 1257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-019-0457-5Best OA location URL: https://europepmc.org/articles/pmc6662627?pdf=renderCitation Count: 236
- Deep brain stimulation induced normalization of the human functional connectome in Parkinson’s disease2019OPENTitle: Deep brain stimulation induced normalization of the human functional connectome in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3129End Page: 3143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz239Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3129/30063714/awz239.pdfCitation Count: 139
- The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin2019OPENTitle: The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and ParkinJournal Name: BiomoleculesPublisher: MDPI AGVol: 9Issue #: 8Start Page: 296End Page: 296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom9080296Best OA location URL: https://www.mdpi.com/2218-273X/9/8/296/pdfCitation Count: 22
- Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm2019OPENTitle: Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigmJournal Name: OncogenePublisher: Springer Science and Business Media LLCVol: 38Issue #: 38Start Page: 6491End Page: 6506Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41388-019-0895-2Best OA location URL: https://www.nature.com/articles/s41388-019-0895-2.pdfCitation Count: 30
- Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease2019OPENTitle: Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s diseaseJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 26Issue #: 3Start Page: 888End Page: 896Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-019-0458-5Best OA location URL: https://www.nature.com/articles/s41380-019-0458-5.pdfCitation Count: 113
-
RESTRICTEDTitle: Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-019-1532-2Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-019-1532-2Citation Count: 77
-
RESTRICTEDTitle: REM sleep behavior disorder predicts functional dependency in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 66Issue #:Start Page: 138End Page: 142Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.025Citation Count: 10
- NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stress2019OPENTitle: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stressJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: 10Start Page: 11223End Page: 11234Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1096/fj.201900830rBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1096/fj.201900830RCitation Count: 79
- The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease2019OPENTitle: The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-019-1394-3Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-019-1394-3Citation Count: 101
-
OPENTitle: miR-34a as hub of T cell regulation networksJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40425-019-0670-5Best OA location URL: https://jitc.bmj.com/content/jitc/7/1/187.full.pdfCitation Count: 44
-
RESTRICTEDTitle: Hallucinations, somatic‐functional disorders of PD‐DLB as expressions of thalamic dysfunctionJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 8Start Page: 1100End Page: 1111Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27781Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707070Citation Count: 55
- Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose2019RESTRICTEDTitle: Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous doseJournal Name: Journal of Pharmaceutical and Biomedical AnalysisPublisher: Elsevier BVVol: 175Issue #:Start Page: 112766End Page: 112766Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jpba.2019.07.014Citation Count: 10
- The value of cerebrospinal fluid α‐synuclein and the tau/α‐synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology2019OPENTitle: The value of cerebrospinal fluid α‐synuclein and the tau/α‐synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathologyJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 1Start Page: 43End Page: 50Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14032Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14032Citation Count: 24
-
OPENTitle: Genetic risk of Parkinson disease and progression:Journal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 5Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000348Best OA location URL: https://ng.neurology.org/content/nng/5/4/e348.full.pdfCitation Count: 135
- Measuring Parkinson's disease over time: The real‐world within‐subject reliability of the MDS‐UPDRS2019OPENTitle: Measuring Parkinson's disease over time: The real‐world within‐subject reliability of the MDS‐UPDRSJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 10Start Page: 1480End Page: 1487Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27790Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27790Citation Count: 125
- The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain2019OPENTitle: The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domainJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 30Start Page: 14979End Page: 14988Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.1900289116Best OA location URL: https://www.pnas.org/content/pnas/116/30/14979.full.pdfCitation Count: 73